Details of the Drug Formulaction

General Information of Drug Formulation (ID: F23205)

Formulation Name
Ivosidenib 250 mg tablet
Company
Agios Pharmaceuticals
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Ivosidenib DM8S6T7 Acute myeloid leukaemia 2A60 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Carmellose sodium E00625 Not Available Disintegrant
Cellulose microcrystalline E00698 Not Available Adsorbent; Suspending agent; Diluent
FD&C blue no. 2 E00446 2723854 Colorant
Hydrophobic colloidal silica E00285 24261 Anticaking agent; Emulsion stabilizing agent; Glidant; Suspending agent; Viscosity-controlling agent
Hypromellose E00634 Not Available Coating agent
Hypromellose acetate succinate E00696 Not Available Coating agent; Solubilizing agent; Modified-release agent;Film/membrane-forming agent
Lactose monohydrate E00393 104938 Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate E00208 11177 lubricant
Sodium lauryl sulfate E00464 3423265 Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent
Triacetin E00080 5541 Humectant; Plasticizing agent; Solvent